問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
馮俊龍
下載
2018-04-01 - 2019-12-31
Condition/Disease
Moderately to Severely Active Crohn's Disease
Test Drug
Upadacitinib (ABT-494)
Participate Sites4Sites
Recruiting3Sites
未分科
2018-04-01 - 2028-12-31
Participate Sites5Sites
Recruiting4Sites
2023-03-01 - 2025-04-30
Participate Sites1Sites
Recruiting1Sites
2022-12-01 - 2029-04-01
2021-07-01 - 2025-09-30
Participate Sites6Sites
Recruiting6Sites
2025-08-01 - 2030-04-30
2024-02-01 - 2027-02-28
2025-06-01 - 2029-01-31
Recruiting5Sites
2018-01-01 - 2023-05-12
2017-12-21 - 2020-04-01
全部
